Diagnostics

We call our Patented Diagnostic PeloFIND-AI

  • Measures a molecular marker of Active wound Infection

  • Uses just a few microliters of wound fluid to measure wound infection status

  • Indicates the level of wound infection within minutes

  • Quantitatively indicates whether infection is improving, staying static, or getting worse from one patient visit to the next

  • The measurement of active wound infection at each patient visit guides the wound physician’s therapeutic management strategy

  • PeloFIND-AI provides NAVIGATIONAL THERAPEUTIC WOUND MANAGEMENT
     

PeloGenix_Meter_Strip.png

Open Wound on Shin


 - Small amount serous drainage
 - Well defined wound edge
 - Chronic wound being treated

 

Concentration of molecular marker of wound infection: 39 μg/mL

Diabetic Foot Ulcer

 

 - Small amount serous drainage
 - Surrounding tissue discolored

    and excoriated
 - Chronic wound being treated

 

Concentration of molecular marker of wound infection: 78 μg/mL

Pressure Ulcer on Heel
 

 - Copious serous drainage
 - Well defined wound edge
 - Chronic wound being treated

 

Concentration of molecular marker of wound infection: 62 μg/mL

CONTROL Acute Wound
3rd Degree Burn

 

 - Small amount serous drainage
 - Surrounding tissue pink

 

Concentration of molecular marker of wound infection: <1 μg/mL

Studies performed to date indicate that the results from PeloFIND-AI group into three ranges as follows:

​

  1. Normal range where there is no active infection in a wound. Found in most Acute wounds on normal healing trajectories.
     

  2. Range of moderately elevated levels of the molecular marker of active infection. Often found in wounds responding to treatment
     

  3. Range of highly elevated levels of the molecular marker of active infection. Found in many newly presenting wounds and wounds not responding to current therapeutic strategy.

​

PeloFIND-AI is expected to have application in other types of active infection causing stress in the human or animal host, including:

​

(a) Periodontal Disease

(i)   periodontitis
(ii)  gingivitis


(b) Chronic Obstructive Pulmonary Disease

(i)   emphysema
(ii)  chronic bronchitis
(iii) refractory (non-reversible) asthma


(c) Cystic Fibrosis